Kelzy

Dienogest/Ethinylestradiol, the active ingredients in Kelzy, are a combined oral contraceptive presented as a tablet for oral use. The formulation provides hormonal birth control by inhibiting ovulation and creating conditions unfavorable for fertilization and implantation. It is prescribed for women of reproductive age seeking reliable contraception.

GNH USA supplies Kelzy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global distribution network ensures consistent quality and regulatory compliance across diverse markets.

Kelzy, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy.

Contraception (prevention of pregnancy): provides reliable hormonal birth control by suppressing ovulation and altering cervical mucus. Menstrual cycle regulation: helps achieve more predictable menstrual bleeding patterns in women using hormonal contraception. Acne management: reduces androgen‑driven skin lesions through hormonal modulation in some women.

Kelzy may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Headache - Breast tenderness - Weight gain - Mood changes - Irregular bleeding

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Myocardial infarction - Severe allergic reaction (anaphylaxis) - Hepatotoxicity

Before prescribing Kelzy, clinicians should consider several safety measures.

Medical evaluation: obtain a thorough medical history to identify contraindications such as thromboembolic disorders. Smoking status: advise against use in women over 35 who smoke heavily. Concurrent medications: review use of enzyme‑inducing drugs that may reduce efficacy. Pregnancy testing: confirm non‑pregnant status before initiating therapy. Breastfeeding: assess risks and benefits, as hormonal exposure may affect lactation. Store at ambient temperature: keep tablets in the original container, protect from moisture and heat.

Kelzy can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase risk of thrombosis. - Hepatic enzyme inducers (e.g., rifampin, carbamazepine): reduce contraceptive effectiveness. - Selective serotonin reuptake inhibitors (e.g., fluoxetine): may increase plasma levels of ethinylestradiol. - Antiretrovirals (e.g., protease inhibitors): may alter hormone metabolism. - St. John’s wort: can diminish contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors): monitor blood pressure changes. - Diuretics: may affect electrolyte balance. - Anticonvulsants with moderate enzyme induction (e.g., phenobarbital): monitor for reduced efficacy. - Antibiotics (e.g., tetracycline): potential minor reduction in absorption. - Herbal supplements (e.g., ginseng): observe for any hormonal interaction.